Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

1(33.3%)

N/A

1(33.3%)

Phase 1

1(33.3%)

3Total

Phase 2(1)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04659889Completed

Clinical and Haematological Phenotypes in Long COVID

Role: lead

NCT02213536Terminated

Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.

Role: lead

NCT01866436Not ApplicableCompleted

Educational Study of Multimedia in Surgical Skills Training in Colorectal Surgery

Role: collaborator

NCT01308762Phase 1Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Role: collaborator

NCT00973999Phase 2Withdrawn

Botulinum Toxin and Saliva Management in Tracheotomised Patients

Role: lead

NCT00972894Unknown

Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study

Role: lead

All 6 trials loaded